Latest Employment News

Aurora Labs has appointed Andrew Garth as chief executive, moving former CEO Rebekah Letheby into a newly focused chief operating role. The reshuffle is intended to separate commercial strategy from technical execution as the company pursues scaled manufacturing and defence opportunities.

DPM Metals says its Vareš operation remains open after Bosnia and Herzegovina’s Constitutional Court found the concession agreement and related land acts were not constitutionally compliant. Authorities now have six months to review the arrangements, leaving the mine operating but its legal framework unresolved.

Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.

Xamble has appointed Adrian Tan permanent CEO and elevated Georg Johann Chmiel to chair as it seeks to convert recent operating improvements into sustained growth. Ganesh Kumar Bangah is stepping down from the board to take a senior Malaysian government-linked role but will remain involved as an adviser and substantial shareholder.

MCS Services has completed the sale of its Traffic Business and now has no operating business, while its ASX securities remain suspended pending a possible recompliance transaction. The company reported $1.77 million in cash at 30 June 2026, but also faces a $495,000 legal settlement and no recurring operating revenue.

St Barbara has secured an ASX waiver that clears the regulatory path for a major redesign of 69.5 million unvested employee rights. Shareholders must still approve the changes, including a 15-year exercise window and dividend equivalent payments.

Taruga Minerals has transformed its exploration strategy around two Papua New Guinea projects, but the next phase comes with a clear funding constraint. The ASX-listed explorer ended FY2026 with A$1.84 million in cash, a A$3.77 million loss and an auditor-highlighted material uncertainty over its ability to continue as a going concern.

Enprise Group’s revenue rose 6% in FY2026, but a sharp earnings deterioration, tight liquidity and an auditor-highlighted going concern uncertainty have left its recovery plan dependent on cost cuts and fresh funding. The NZX-listed software group is targeting a return to profitability in FY2027 after refinancing and restructuring its largest business.

Rhythm Biosciences has moved ColoSTAT and geneType into commercial use, recording its first sales during FY2026. But with sales revenue of just $85,339, a $5.93 million loss and an auditor-flagged going-concern uncertainty, the next phase will be judged on cash generation and repeat adoption.

OpenLearning has signed a five-year LMS agreement worth a minimum A$1.75 million with one of the Philippines’ largest private education institutions. The contract does not begin until July 2027, but marks the company’s biggest LMS SaaS win in the country.

Nufarm is pairing a narrower crop-protection portfolio with heavier investment in seeds and tighter capital controls as it targets A$370 million to A$380 million in FY26 underlying EBITDA. The company has reaffirmed positive free cash flow, leverage of about 2.0 times and a A$50 million cost-saving program due to reach run-rate by the end of FY27.

Bremworth has restored internal yarn production, cut costs and improved its inventory profile, but FY26 still ended with an NZ$11.4 million loss. The company now enters FY27 under new ownership and board dynamics, with positive operating cash flow still to be achieved.